USA India Chamber of commerce

Follow us on

Tweets by @USAIC

Photo Gallery

Policy & Reports

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

As a service to the BioPharma community in these unprecedented times, USAIC is offering Free Registration for its annual summit.

17^th Annual BioPharma & Healthcare Summit, Wednesday, May 3, 2023 - Virtual Meeting

2022 Speakers and Contributors
Dr. Lawrence Tabak Acting Director National Institutes of Health	Dr. Andrew Plump President of R&D Takeda Pharmaceutical	Dr. Julie Gerberding Chief Executive Officer Foundation for the NIH	Alex Gorsky Executive Chairman Johnson & Johnson	Dr. Stelios Papadopoulos Chairman of the Board Biogen

Dr. Mathai Mammen Exe. Vice President, Pharma, R&D Johnson & Johnson	Dr. David Reese Executive Vice President- R&D Amgen	Kiran Mazumdar Shaw Executive Chairperson Biocon	Christopher Viehbacher Founding Partner Gurnet Point Capital	Dr. Vinod Paul Member NITI Aayog

Dr. John Reed Global Head of R&D Sanofi	Hari Bhartia Founder & Co-Chairman Jubilant Bhartia Group	Jennifer Fox Chief Financial Officer Nuvation Bio	Dr. Alise Reicin Chief Executive Officer Tectonic Therapeutic	Dr. Elias Zerhouni Professor Emeritus Johns Hopkins University

Dr. Martin Mackay Co-Founder Rallybio	Dr. Naresh Trehan Chairman Medanta - the Medicity	Paula Soteropoulos Chairman of the Board Ensoma	Dr. Cynthia Verst President, R&DS IQVIA	Dr. Todd Golub Director Broad Institute of MIT and Harvard

Sastry Chilukuri Co-CEO Medidata	Dr. Eric Rubin SVP, TA Head Oncology, Early Dev. Merck Research Laboratories	Dr. Christina Trojel-Hansen Chief Executive Officer Regenerative Medicine Newco	Dr. Najat Khan Chief Data Science Officer Janssen R&D, Johnson & Johnson	Dr. Philip Larsen Global Head of Research Bayer AG

Dr. John Mascola Chief Scientific Officer ModeX Therapeutics	Peter Ronco Head, Global Development Janssen R&D	Daphne Zohar Founder & CEO PureTech Health	Dr. Simone Fishburn Editor in Chief BioCentury	Dr. William Chin Professor of Medicine, Emeritus Harvard Medical School

Dr. Timothy Yu Associate Professor in Pediatrics Harvard Medical School	Dr. Al Sandrock Chief Executive Officer Voyager Therapeutics	Dr. Karen Akinsanya President of R&D, Therapeutics Schrodinger	Dr. Regina Barzilay Distinguished Professor for AI & Health Massachusetts Institute of Technology	Dr. Shiv Kumar Sarin Vice Chancellor Institute of Liver & Biliary Sciences

Rajiv Kaul Portfolio Manager Fidelity Investments	Dr. Samuel Waksal Chairman & CEO Équilibre Biopharmaceuticals	Dr. Christine K Ward VP, Head of Oncology Takeda	Charlene Son Rigby Chief Executive Officer RARE-X	Dr. David Meeker Chairman & CEO Rhythm Pharmaceuticals

Dr. Samarth Kulkarni Chief Executive Officer CRISPR Therapeutics	Max Bronstein Assistant Director for Health Innovation White House OSTP	Stephanie Lee Griffin Vice President Roivant Sciences	Dr. Lina Williamson Co-founder, President & CIO TMA Precision Health	Dr. Sanjeev Sinha Professor of Medicine All India Institute of Medical Sciences

Chris Benko Co-Founder & CEO Koneksa Health	Dr. Dhaval Patel EVP & Chief Scientific Officer UCB	Dr. Karen Reeves President & Chief Medical Officer AZTherapies	Olga Granaturova Co-Founder & COO Parthenon Therapeutics	Dr. Kush Parmar Managing Partner 5AM Ventures

Dr. Vipin Gopal Chief Data & Analytics Officer Eli Lilly	Dr. Osaze Udeagbala BD Transactions Lead (GI) Takeda Pharmaceuticals	Dr. Barry Ticho Chief Medical Officer Stoke Therapeutics	Dr. Syed Kazmi Chief Executive Officer Jubilant Therapeutics	Rehan Verjee Co Founder and CEO Stealth start-up

© 2007 - USA India Chamber of Commerce

| | | | | | | | |